MeD-Seq, a novel method to detect DNA methylation genomewide

Thursday, October 17, 2019
10:30 AM CEST

Next-Generation Sequencing (NGS) is opening new avenues for epigenetic research by unleashing mechanisms that shape cell- and disease-specific gene expression programs. Although technical challenges still exist, having NGS technologies featuring simple workflow, high-throughput capability, and high-quality readout with minimal sequencing depth will help to enable further breakthroughs.

Join our webinar presented by Dr ir Wilfred van IJcken (Board Member of Methylomics and Manager of Erasmus Center for Biomics, Erasmus medical Center Rotterdam, The Netherlands) to learn about a newly developed method for genome-wide detection of DNA methylation.

This webinar will cover the following topics:

  • Background on DNA methylation
  • Key aspects of the novel MeD-Seq method
  • Validation data of MeD-Seq
  • Real showcase on cervical cancer after hrHPV infection

Wilfred van IJcken, PhD


Wilfred van IJcken, PhD
Methylomics, Board member and Manager of Erasmus Center for Biomics
Erasmus medical Center Rotterdam, The Netherlands


Fill out the form to the right to register. If you cannot attend the live webinar, please register anyhow, and we will send you the presentation so you can catch up on our latest technology.